Skip to main content

2 Result(s)

within Ralph Wong Remove this filter

and

  1. No Access

    Article

    A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma

    Purpose: This phase II study explored the efficacy and tolerability of pegylated liposomal doxorubicin (PLD) given on a 2 week schedule in patients with advanced malignant melanoma previously unt...

    Michael G. Smylie, Ralph Wong, Catalin Mihalcioiu, Chris Lee… in Investigational New Drugs (2007)

  2. No Access

    Article

    Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)

    Background: The primary objective of this Phase I study was to determine the maximum tolerated dose (MTD) and recommended phase II dose for Tomudex and doxorubicin when given in combination to patients w...

    Georg A. Bjarnason, Danielle Charpentier, Ralph Wong… in Investigational New Drugs (2005)